339 related articles for article (PubMed ID: 19844125)
1. Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study.
Romer T; Saenger P; Peter F; Walczak M; Le Bouc Y; Khan-Boluki J; Berghout A
Horm Res; 2009; 72(6):359-69. PubMed ID: 19844125
[TBL] [Abstract][Full Text] [Related]
2. Long-term safety and efficacy of the recombinant human growth hormone Omnitrope® in the treatment of Spanish growth hormone deficient children: results of a phase III study.
López-Siguero J; Borrás Pérez MV; Balser S; Khan-Boluki J
Adv Ther; 2011 Oct; 28(10):879-93. PubMed ID: 21948492
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind study to assess the efficacy and safety of valtropin, a biosimilar growth hormone, in children with growth hormone deficiency.
Peterkova V; Arslanoglu I; Bolshova-Zubkovskaya E; Romer T; Zdravkovic D; Kratzsch J; Ji HJ; Savoy C; Saenger P
Horm Res; 2007; 68(6):288-93. PubMed ID: 17627092
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence studies of omnitrope, the first biosimilar/rhGH follow-on protein: two comparative phase 1 randomized studies and population pharmacokinetic analysis.
Stanhope R; Sörgel F; Gravel P; Pannatier Schuetz YB; Zabransky M; Muenzberg M
J Clin Pharmacol; 2010 Nov; 50(11):1339-48. PubMed ID: 20173088
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the oxidant-antioxidant status in prepubertal children with growth hormone deficiency: effect of growth hormone replacement therapy.
Mohn A; Marzio D; Giannini C; Capanna R; Marcovecchio M; Chiarelli F
Clin Endocrinol (Oxf); 2005 Nov; 63(5):537-42. PubMed ID: 16268806
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
9. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
Lanes R; Jakubowicz S
J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186
[TBL] [Abstract][Full Text] [Related]
10. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
11. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
Seminara S; Stagi S; Candura L; Scrivano M; Lenzi L; Nanni L; Pagliai F; Chiarelli F
Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study.
Iughetti L; Tornese G; Street ME; Napoli F; Giavoli C; Antoniazzi F; Stagi S; Luongo C; Azzolini S; Ragusa L; Bona G; Zecchino C; Aversa T; Persani L; Guazzarotti L; Zecchi E; Pietropoli A; Zucchini S
Ital J Pediatr; 2016 Nov; 42(1):93. PubMed ID: 27809913
[TBL] [Abstract][Full Text] [Related]
14. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment.
Wu KH; Tsai FJ; Peng CT
Ann Hematol; 2003 Oct; 82(10):637-40. PubMed ID: 12898188
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
Giovenale D; Meazza C; Cardinale GM; Farinelli E; Mastrangelo C; Messini B; Citro G; Del Vecchio M; Di Maio S; Possenti I; Bozzola M
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
[TBL] [Abstract][Full Text] [Related]
18. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
[TBL] [Abstract][Full Text] [Related]
19. Decreased GH dose after the catch-up growth period maintains metabolic outcome in short prepubertal children with and without classic GH deficiency.
Decker R; Albertsson-Wikland K; Kriström B; Halldin M; Dahlgren J
Clin Endocrinol (Oxf); 2012 Sep; 77(3):407-15. PubMed ID: 22417085
[TBL] [Abstract][Full Text] [Related]
20. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
Carvalho LR; de Faria ME; Osorio MG; Estefan V; Jorge AA; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
